We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Regulating Off-Label Info On Drugs, Medical Devices

Law360 (February 2, 2009, 12:00 AM EST) -- In the waning days of the Bush administration, the U.S. Food and Drug Administration released a controversial new guidance document providing recommendations to manufacturers of drugs, medical devices and licensed biologics...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.